Title:Breast Cancer and Anesthesia
Volume: 25
Issue: 28
Author(s): Aida Raigon-Ponferrada, María E.D. Recio*, Jose L. Guerrero-Orriach*, Alfredo Malo-Manso, Juan J. Escalona-Belmonte, Marta R. Aliaga, Alicia R. Fernández, Francisco J.F. García, Emilio A. Conejo and José Cruz-Mañas
Affiliation:
- Institute of Biomedical Research in Malaga [IBIMA], Malaga,Spain
- Institute of Biomedical Research in Malaga [IBIMA], Malaga,Spain
Keywords:
Anesthetic drugs and techniques, opioids, propofol, volatile agent, breast cancer, cancer recurrence, immune cells, natural killer
cells.
Abstract:
Breast cancer is a complex heterogeneous disease that is categorized into several histological and genomic
subtypes with relevant prognostic and therapeutical implications. Such diversity requires a multidisciplinary
approach for a comprehensive treatment that will involve surgeons, radiotherapists and medical oncologists.
Breast cancer is classified as either local (or locoregional), which stands for 90-95% of cases, or metastatic, representing
5% of cases.
The management of breast cancer will be determined by the stage of the disease. The treatment of local breast
cancer is based on surgery and/or radiotherapy. Systemic breast cancer requires chemotherapy and/or endocrine
and/or biological therapy.